TAMPA, Fla., Jan. 17, 2025 /PRNewswire/ — Business Integrity Services (BIS), a trusted leader in operational and business process solutions, proudly announces its achievement of ISO 9001:2015 and ISO 27001:2022 certifications. These globally recognized standards reflect BIS’s dedication to delivering exceptional quality management and ensuring the highest levels of information security for its clients.
ISO 9001:2015 focuses on quality management systems, emphasizing a client- centered approach, consistent service delivery, and continuous improvement. ISO 27001:2022 highlights BIS’s commitment to implementing a robust framework for managing and protecting sensitive information. Together, these certifications underscore BIS’s mission to drive operational excellence and instill confidence among its clients.
“Achieving ISO certification is a testament to our relentless commitment to quality, security, and operational excellence. At BIS, we continuously strive to exceed global standards, ensuring our clients receive the highest level of service and trust,” said Phil Burk, Chief Operating Officer, Business Integrity Services.
This milestone reinforces BIS’s position as a trusted partner in the industry and aligns with the company’s mission to drive operational excellence for its clients worldwide.
About Business Integrity Services (BIS):
Business Integrity Services specializes in providing comprehensive solutions for Revenue Cycle Management, Patient Scheduling, Medical Records Management, Medical Coding, Credentialing, Business Analytics, IT Support, and many other supporting services. With a focus on quality and innovation, BIS empowers businesses to achieve their goals efficiently and securely.
For more information, visit www.businessintegrityservices.com or contact our corporate office at 1 (800) 592-6079.
Contact Information:
Jenny.G@thebisteam.com
+1 800-592-6079
www.businessintegrityservices.com
5501 West Gray Street Tampa, FL 33609
SOURCE Business Integrity Services
CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…
Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…
Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…
Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…
Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…
Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…